Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

A subunit cytomegalovirus vaccine based on recombinant envelope glycoprotein B and a new adjuvant.

A subunit cytomegalovirus vaccine based on recombinant envelope glycoprotein B and a new adjuvant. J Infect Dis. 1999 Oct; 180(4):970-5.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.